65.9 F
San Diego
Wednesday, Apr 24, 2024
-Advertisement-

Synthetic Genomics Gets $50M as Part of Effort to Grow Organs in Pigs for Human Use

San Diego’s Synthetic Genomics Inc. is teaming up with Lung Biotechnology, a subsidiary of pharma giant United Therapeutics of Silver Spring, Maryland, to develop “humanized” lungs and other organs in pigs that can be harvested for human transplantation.

Lung Biotechnology has committed a $50 million equity investment to Synthetic Genomics in the multiyear deal.

“We believe this is one of the most exciting and important programs ever undertaken in modern medical science,” J. Craig Venter, founder and CEO of Synthetic Genomics, said in a statement.

Venter is a storied San Diego scientist whose contributions were critical to the success of the Human Genome Project, among others.

For more information, click here.

-Advertisement-

Featured Articles

Hair Today, Hair Tomorrow

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-